GlobalData predicts product cannibalization within electrophysiology ablation space
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
New-generation cardiac ablation technology expands treatment options for atrial fibrillation patients, offering a non-thermal approach to improve safety and procedural efficiency
Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
Under the deal, Quiver will receive an undisclosed advance payment and research support
Subscribe To Our Newsletter & Stay Updated